These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2844549)

  • 21. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma.
    Ducharme FM; Davis GM
    J Pediatr; 1998 Oct; 133(4):479-85. PubMed ID: 9787684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors.
    Bauer K; Kaik G; Kaik B
    Hypertension; 1994 Sep; 24(3):339-46. PubMed ID: 7916004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term trial of ketotifen in bronchial asthma.
    Podleski WK; Zelenak TM; Schmidt JL
    Ann Allergy; 1984 Jun; 52(6):406-10. PubMed ID: 6428279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol.
    Lipworth BJ; Clark RA; Dhillon DP; McDevitt DG
    Eur J Clin Pharmacol; 1990; 38(2):203-5. PubMed ID: 2159886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ; Struthers AD; McDevitt DG
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebulized ipratropium in the treatment of acute asthma.
    Summers QA; Tarala RA
    Chest; 1990 Feb; 97(2):425-9. PubMed ID: 2137076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulized beta 2-adrenoceptor agonists do not affect plasma selenium or glutathione peroxidase activity in patients with asthma.
    Burgess CD; Bremner P; Thomson CD; Crane J; Siebers RW; Beasley R
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):290-2. PubMed ID: 7921529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketotifen prevents terbutaline-induced down-regulation of beta-adrenoceptors in guinea pig lung.
    Koshino T; Agrawal DK; Townley TA; Townley RG
    Biochem Biophys Res Commun; 1988 May; 152(3):1221-7. PubMed ID: 2897844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients.
    Románski B; Pawlik-Miskiewicz K; Wilewska-Klubo T
    Allergol Immunopathol (Madr); 1983; 11(1):34-9. PubMed ID: 6407291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of adding ketotifen to ipratropium bromide in the treatment of nocturnal asthma.
    Carpentiere G; Marino S; Castello F; Bonanno CT; Pedalino G
    Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):543-5. PubMed ID: 2978900
    [No Abstract]   [Full Text] [Related]  

  • 31. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients.
    Fontana G; Mugnai M; Cresci F; Panuccio P
    Respiration; 1986; 50 Suppl 2():201-5. PubMed ID: 2951806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of ketotifen action in hypersensitivity reactions. Its effect on cellular enzymatic activities.
    Castillo JG; Oehling A; Gamboa PM
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):315-23. PubMed ID: 1669589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
    Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
    Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.
    Haney S; Hancox RJ
    Respir Res; 2007 Mar; 8(1):19. PubMed ID: 17341317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the bronchodilator activity of Sch 1000 and salbutamol.
    Ruffin RE; Fitzgerald JD; Rebuck AS
    J Allergy Clin Immunol; 1977 Feb; 59(2):136-41. PubMed ID: 137922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.
    Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
    Smyth ET; Pavord ID; Wong CS; Wisniewski AF; Williams J; Tattersfield AE
    BMJ; 1993 Feb; 306(6877):543-5. PubMed ID: 8096416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketotifen and nocturnal asthma.
    Catterall JR; Calverley PM; Power JT; Shapiro CM; Douglas NJ; Flenley DC
    Thorax; 1983 Nov; 38(11):845-8. PubMed ID: 6359563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.